Dudediligence.

Damora Therapeutics, Inc

DMRANASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 1010-QQuarterly report
  2. Jul 2813GPassive stake of 5% or more (13G), filed by BlackRock
  3. Jul 208-KMaterial agreement and bylaws or fiscal year changed1.013.035.037.019.01
  4. Jun 178-KShareholder vote5.07
  5. May 1210-QQuarterly report
  6. May 48-KOfficer or director change5.029.01
  7. Apr 208-KChange of auditor4.019.01
  8. Mar 238-KOfficer or director change and Regulation FD disclosure5.027.019.01
  9. Mar 1910-KAnnual report
  10. Mar 108-KResults of operations and bylaws or fiscal year changed2.025.037.019.01
  11. Feb 118-KMaterial agreement1.019.01
  12. Feb 11424B5Prospectus for an offering
  13. Feb 10424B5Prospectus for an offering
  14. Feb 108-KOfficer or director change and bylaws or fiscal year changed5.025.038.019.01
  15. Jan 128-KRegulation FD disclosure7.019.01
  16. Jan 68-KUnregistered sale of shares and officer or director change3.025.029.01
  17. Dec 31, 2025424B3Prospectus for an offering
  18. Dec 16, 2025S-3Shelf registration
  19. Dec 9, 20258-K/ABylaws or fiscal year changed (amended)5.039.01
  20. Nov 10, 20258-KMaterial agreement and acquisition or sale of assets completed1.012.013.025.025.037.019.01
  21. Nov 6, 202510-QQuarterly report
  22. Aug 5, 202510-QQuarterly report
  23. Jun 20, 20258-KShareholder vote5.07
  24. May 8, 202510-QQuarterly report
  25. Mar 19, 202510-KAnnual report
  26. Nov 1, 202410-QQuarterly report
  27. Oct 15, 20248-KOfficer or director change5.029.01
  28. Oct 7, 20248-KMaterial agreement and acquisition or sale of assets completed1.012.013.025.025.037.019.01